The US measles elimination status remained under review as of November 6, 2026. The Pan American Health Organization had scheduled a verification meeting for November 10–13, but it had not announced a decision. The United States still held elimination status, despite recording 4,852 confirmed cases through October 29 and its largest outbreak in roughly 30 years.
Seven facts about the US measles elimination status
-
Elimination has been in place since 2000. The CDC says measles was declared eliminated in the United States in 2000. Elimination doesn’t mean that the country will never record another case; it concerns whether measles transmission has become continuously established again.
-
The 2026 case count is unusually high. The CDC had recorded 4,852 confirmed cases through October 29, 2026. That preliminary total was more than twice the 2,289 cases reported during all of 2025 and could change as investigations were completed.
-
Most cases were connected to outbreaks. The CDC identified 43 outbreaks in 2026 through October 29. Of all confirmed cases, 4,666, or 96%, were outbreak-associated rather than isolated reports.
-
Vaccination status is a consistent dividing line. In 2026, 96% of cases occurred in people who were unvaccinated against measles, mumps and rubella or whose MMR vaccination status was unknown. The comparable share was 93% in 2025. Unknown status prevents a perfect vaccinated-versus-unvaccinated comparison, but the pattern remains stark.
-
School coverage is below the national target. CDC data put two-dose MMR coverage among US kindergarten students at 92.4% for the 2025–2026 school year, below the 95% target. A national average can also hide communities and schools with substantially lower coverage.
-
One outbreak approached 1,000 cases. South Carolina recorded 997 cases between October 2025 and March 2026. The CDC described it as the country’s largest measles outbreak in about 30 years, making it central to the US measles elimination status review.
-
The final decision belongs to a regional verification process. PAHO announced on October 14, 2026 that its Regional Verification Commission would meet November 10–13 to review measles epidemiology and national elimination status. As of November 6, no US ruling had been published, and a final report was expected after the meeting.
How unusual are the 2026 numbers?
The rise is easier to see across several reporting years. The 2026 preliminary count was nearly 17 times the 285 cases reported in 2024, and about 3.8 times the 1,274 cases recorded during the major resurgence of 2019.
| Reporting period | Confirmed US cases | Data status |
|---|---|---|
| 2019 | 1,274 | CDC final count |
| 2024 | 285 | CDC final count |
| 2025 | 2,289 | CDC final count |
| 2026 through October 29 | 4,852 | CDC preliminary count |
Raw totals aren’t the only measure used to assess elimination. Investigators also examine how cases are linked, how long the same transmission chain persists, the quality of surveillance and whether outbreaks can be traced to imported infections.
A May 2, 2026 correspondence in The Lancet concluded that the United States had missed four of seven CDC measles-elimination indicators. It reported an early-2026 incidence of about 93 cases per 10 million people. That was an indicator analysis, not PAHO’s official determination, so it should be read as a warning signal rather than a verdict.
What losing elimination status would mean
A loss of the US measles elimination status would indicate that sustained transmission had again become established under the regional verification criteria. It would not mean every state had endemic measles, nor would it mean vaccination had stopped working.
Canada offers a close comparison. On November 10, 2025, Canada lost elimination status after transmission of the same measles strain continued for more than one year. Canadian authorities declared the associated multi-jurisdictional outbreak over on October 19, 2026, after more than two months without a linked case, but said ending the outbreak did not automatically restore the designation.
Status matters because it summarizes more than a single year’s case count. It reflects whether public health systems can detect infections, trace transmission and prevent imported cases from developing into prolonged chains. For broader context on how these chains develop, see our detailed coverage of the 2026 measles outbreak.
Honestly, arguing over the label can distract from the immediate problem. Thousands of confirmed infections and dozens of outbreaks matter to families and schools regardless of what the commission ultimately calls the national status.
Vaccination coverage and the overlooked local gap
The CDC estimates that one MMR dose is about 93% effective against measles, while two doses are about 97% effective. Put another way, among 1,000 similarly exposed vaccinated people, the approximate number not protected by the vaccine’s average effectiveness would fall from 70 after one dose to 30 after two doses. That is a simplified calculation, not a prediction of how many people will become infected.
The national kindergarten coverage figure also needs careful reading. At 92.4%, the gap from the 95% target is 2.6 percentage points. In a hypothetical group of 10,000 kindergarten students, that difference represents 260 fewer children covered than at 95%, assuming the percentages apply evenly.
They don’t apply evenly. National and state averages can conceal clusters of undervaccination where measles has more opportunities to spread. That local clustering is an often-missed caveat when people compare a 92.4% average with a 95% target as though every child were distributed randomly across the country.
MMR vaccination remains the main preventive tool, and the 2026 case distribution supports its value. Our guide to vaccination and infectious-disease prevention explains why community coverage matters as well as individual protection.
What you can do while the decision is pending
You don’t need to wait for a PAHO ruling to check your own situation. Review your vaccination records and your children’s school records, particularly before international travel or if measles is circulating locally. If records are missing, a clinician or immunization program can help determine the appropriate next step.
Don’t assume that an unknown record means you’re protected, but don’t improvise a vaccination schedule either. Recommendations can differ according to age, previous doses, pregnancy, immune status and outbreak exposure. Ask a qualified clinician or local health department for advice tailored to you, and don’t delay medical guidance if you may have been exposed or develop symptoms.
The pending US measles elimination status decision may clarify how regional authorities classify transmission. It won’t change the practical priorities: accurate surveillance, quick outbreak control and higher vaccination coverage in communities where immunity gaps are concentrated.
Frequently asked questions
Has the United States already lost measles elimination status?
No. As of November 6, 2026, PAHO had not published a decision. Its Regional Verification Commission was scheduled to review elimination status on November 10–13, with a report expected afterward.
Why can measles cases occur after elimination?
Elimination doesn’t mean zero cases. Imported infections and outbreaks can still occur; the central question is whether transmission becomes continuously established again.
How many US measles cases were reported in 2026?
The CDC reported a preliminary 4,852 confirmed cases through October 29, 2026. Of those, 4,666 were associated with 43 outbreaks.
Does the MMR vaccine fully prevent measles?
No vaccine is perfect. The CDC estimates one MMR dose is about 93% effective against measles and two doses are about 97% effective.
Can the United States regain elimination status if it loses it?
A country can be re-verified after meeting the applicable regional criteria, but ending one outbreak doesn’t automatically restore status. Canada’s October 2026 announcement made that distinction explicit.


